Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 15, Issue 1, 2003, Pages 78-83

  Lee, Kang U ^a   Lee, Jae S ^b   Kim, Ki W ^c   Jhoo, Jin H ^c   Lee, Dong Y ^c   Yoon, Jong C ^c   Lee, Jung H ^a   Lee, Dong S ^b   Lee, Myung C ^b   Woo, Jong I ^b,c  

^a Kangwon National University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; FLUORODEOXYGLUCOSE F 18;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; COMPUTED TOMOGRAPHY SCANNER; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; TEMPORAL LOBE;

EID: 0037412755     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.15.1.78     Document Type: Article

References (38)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al: Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90:1977-1981
2. Rebeck GW, Reiter JS, Strickland DK, et al: Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11:575-580
3. Saunders AM, Strittmatter WJ, Schmechel D, et al: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43:1467-1472
4. Ueki A, Kawano M, Namba Y, et al: A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset non-familial Alzheimer's disease. Neurosci Lett 1993; 163:166-168
5. Blacker D, Haines JL, Rodes L, et al: ApoE-4 and age at onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology 1997; 48:139-147
6. Schmechel DE, Saunders AM, Strittmatter WJ, et al: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of an apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90:9649-9653
7. Strittmatter, WJ, Saunders AM, Goedert M, et al: Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci USA 1994; 91:11183-11186
8. Poirier J, Delisle M-C, Quirion R, et al: Apolipoprotein ε4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc Natl Acad Sci USA 1995; 92:12260-12264
9. Smith GE, Bohac DL, Waring SC, et al: Apolipoprotein E genotype influences cognitive "phenotype" in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998; 50:355-362
10. Lehtovirta M, Soininen H, Helisalmi S, et al: Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996; 46:413-419
11. Juottonen K, Lehtovirta M, Helisalmi S, et al: Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele. J Neurol Neurosurg Psychiatry 1998; 65:322-327
12. Lehtovirta M, Laakso MP, Soininen H, et al: Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995; 67:65-72
13. Jelic V, Julin P, Shigeta M, et al: Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. J Neurol Neurosurg Psychiatry 1997; 63:59-65
14. Lehtovirta M, Partanen J, Kononen M, et al: Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurobiol Aging 1996; 17:523-526
15. Duara R, Grady C, Haxby J, et al: Positron emission tomography in Alzheimer's disease. Neurology 1986; 36:879-887
16. Foster NL, Chase TN, Fedio P, et al: Alzheimer's disease: focal changes shown by positron emission tomography. Neurology 1983; 33:961-965
17. Pietrini P, Azari NP, Grady CL, et al: Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation. Dementia 1993; 4:94-101
18. Reiman EM, Caselli RJ, Yun LS, et al: Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N Engl J Med 1996; 334:752-758
19. Small GW, Mazziotta JC, Collins MT, et al: The effect of apolipoprotein E type 4 allele on cerebral glucose metabolism in relatives at risk for Alzheimer disease. JAMA 1995; 273:942-947
20. Hirono N, Mori E, Yasuda M, et al: Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer's disease. Alzheimer Dis Assoc Disord 1998; 12:362-367
21. Corder EH, Jelic V, Basun H, et al: No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch Neurol 1997; 54:273-277
22. Murphy GM, Taylor J, Kraemer HC, et al: No association between apolipoprotein E ε4′ allele and rate of decline in Alzheimer's disease. Am J Psychiatry 1997; 154:603-608
23. Dal Forno G, Rasmusson DX, Brandt J, et al: Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996; 53:345-350
24. Mckhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 11:939-944
25. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
26. Lee JH, Lee KU, Lee DY, et al: Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and Neuropsychological Assessment Batteries. J Gerontol B Psychol Sci 2002; 57:47-53
27. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
28. Rosen WG, Terry RD, Fuld PA, et al: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980; 7:486-488
29. Hughes CP, Berg L, Danziger W, et al: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
30. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337:1158-1159
31. Minoshima S, Frey KA, Foster NL, et al: Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 1995; 19:541-547
32. Craft S, Teri L, Edland SD, et al: Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 1998; 51:149-153
33. Basun H, Grut M, Winblad B, et al: Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995; 183:32-34
34. Stern Y, Brandt J, Albert M, et al: The absence of an apolipoprotein ε4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 1997; 41:615-620
35. McNamara MJ, Gomez-Isla T, Hyman BT: Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer's disease. Arch Neurol 1998; 55:1001-1004
36. Beffert U and Poirier J: Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann NY Acad Sci 1996; 777:166-174
37. 18F] FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 1999; 9:63-80
38. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. New York, Thieme Medical, 1988